OR WAIT null SECS
May 02, 2012
Poland's government aims to make the Eastern European country a biotech powerhouse.
April 05, 2012
The management board of the European Medicines Agency has introduced a range of new measures to strengthen and extend its conflicts of interest policy for scientific-committee members and experts, as well as for members of the management board.
February 15, 2012
The EMA has published a guideline that addresses the influence of patients? genetic variability on drug pharmacokinetics.
January 02, 2012
The European Union market takes steps toward continuous processing and modular facilities.
December 01, 2011
EMA Hosts Subgroup Analysis Workshop.
November 10, 2011
EMA Issues Concept Paper for Public Consultation on Development of Toxicological Guidance for use in Risk Identification.
November 01, 2011
In an age dominated by the internet and uncertainty over the best packaging security methods to employ, counterfeit medicines have the ideal environment to thrive.
July 07, 2011
The European Medicines Agency has responded positively to a new directive published in the Official Journal of the European Union addressing concerns over increases in falsified medicines in the supply chain.
July 02, 2011
Member states in the EU are working to implement the newly passed Falsified Medicines Directive.
June 30, 2011
The European Medicines Agency (EMA) has held a second forum regarding the implementation of new pharmacovigilance legislation, which gave stakeholders the opportunity to discuss their expectations on various aspects of the new legislation's execution.